Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Business & People

TITLE:

APBI: NICE recommends to maintain medicines access for patients with severe rheumatoid arthritis

BRIEF:

 The ABPI welcomes the publication of the National Institute of Health and Care Excellence (NICE) final appraisal determination (FAD) for rheumatoid arthritis which recommends continued access to biologic medicines for patients living with severe rheumatoid arthritis.

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company